Pharmaceuticals

Clinical Trial Investigative Site Network Market Size, Share & Trends Analysis Report By Therapeutic Area (Oncology, Cardiology, Central Nervous System (CNS), Endocrine & Metabolic Disorders, Infectious Diseases, Pain & Inflammation, Rare & Orphan Diseases, Others),By Phase (Phase I, Phase II, Phase III, Phase IV),By End User, By Region and Segments Forecasts, 2025-2034

Global Clinical Trial Investigative Site Network Market Size is valued at USD 8.5 Bn in 2024 and is predicted to reach USD 17.5 Bn by the year 2034 at a 7.50% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The need for investigative site networks is driven by the fact that clinical trials are essential in establishing the effectiveness and legitimacy of new medicines. Clinical trials are ...

Report ID: 1486  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 188

Cell Line Development Market Size, Share & Trends Analysis Report By Offering (Cell Line Development Services, Cell Line Development Products), By Host Cell Type (CHO (CHO-K1, CHO-S, DG44 variants), HEK293 / PER.C6, NS0 / Sp2/0 (Hybridoma), Microbial (E. coli, Pichia pastoris), Insect (Sf9/Sf21), Other (Avian / Plant / Novel systems)), By Application / Molecule Type ( Monoclonal & Bispecific Antibodies, Recombinant Proteins & Enzymes Vaccines (Subunit / VLP / Recombinant), Gene & Cell Therapy Vectors (AAV / LV producer lines), Others (Hormones, Fusion Proteins, Cytokines), By Scale of Operation, By End-User Type, By Region and By Segment Forecasts, 2025-2034.

Global Cell Line Development Market Size is valued at USD 1162.61 Mn in 2024 and is predicted to reach USD 3790.05 Mn by the year 2034 at a 12.6% CAGR during the forecast period for 2025-2034. Cell line development creates highly productive, stable cell lines required for bio-therapeutic production and manufacture. These single-celled organisms create vaccines, monoclonal antibodies, and fusion proteins. Thousands of clones are screened during t...

Report ID: 2306  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Synthetic Biology Vaccines Market Size, Share & Trends Analysis Distribution, by Type (mRNA Synthetic Vaccines, Protein/Peptide Synthetic Vaccines, Vector-based Synthetic Vaccines, and DNA Synthetic Vaccines), By Application (Infectious Diseases, Autoimmune & Genetic Diseases, Cancer Immunotherapy, and Pandemic & Epidemic Applications), By Platform Technology (CRISPR-Based Design, Cell-Free Systems, and AI-Assisted Biofabrication), By End-use (Hospitals, Biotech & Pharmaceutical Companies, and Research Institutions), and Segment Forecasts, 2025-2034

Global Synthetic Biology Vaccines Market Size is predicted to grow with an 16.00% CAGR during the forecast period for 2025-2034. The development and production of next-generation vaccines using synthetic biology techniques, including gene editing, cell-free expression, and synthetic genomics, is the main focus of the synthetic biology vaccines market. These vaccines have advantages over traditional vaccines in terms of safety and scalability, an...

Report ID: 3254  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 170

CBD API Market Size, Share & Trends Analysis Report By Source Type (Natural CBD API (Plant-Derived),Synthetic CBD API), By End Use / Application (Pharmaceuticals, Nutraceuticals & Dietary Supplements, Cosmetics & Personal Care, Research & Development / Clinical Use), By End User (Pharmaceutical & Biotech Companies, Nutraceutical / Supplement Manufacturers, Cosmetic & Personal Care Companies, Contract Manufacturing Organizations (CMOs) / CDMOs, Research Institutions & CROs), By Purity / Grade, By Form / Composition, By Region and By Segment Forecasts, 2025-2034

Global CBD API Market growth is valued at US$ 521.94 Mn in 2024 and is expected to reach US$ 2233.37 Mn by 2034, with a CAGR of 15.8% during the forecast period of 2025-2034. Key Industry Insights & Findings from the report: CBD has been recommended for a range of health conditions, it is considered the best treatment while considering the worst childhood epilepsy disorders. The increasing demand for health and wellne...

Report ID: 1478  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

RNA-based Therapeutics Market Size, Share & Trends Analysis Report By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, RNA Aptamer, Other Therapeutics), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Oncology, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Others), By Delivery Mechanism (Lipid Nanoparticles (LNPs), Polymer-Based Nanoparticles, Viral Vectors, Naked RNA), By End User, By Region and By Segment Forecasts, 2025-2034

Global RNA-based Therapeutics Market is valued at USD 12.4 Bn in 2024 and is predicted to reach USD 22.6 Bn by the year 2034 at a 6.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The growing biopharmaceutical sector, characterized by increased investment and interest in innovative therapies, is propelling the RNA-based therapeutics market. The entry of new biotech startups focused on R...

Report ID: 1151  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 185

Immuno-Oncology Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (CAR-T Cells, NK & NKT Cells, TAA/TSA targeted T Cell, TCR T Cell, and Other Cell Therapies), By Cell Source, By Indication Type, By Region, And Segment Forecasts, 2025-2034

Global Immuno-Oncology Cell Therapy Market Size is valued at USD 11.9 Billion in 2024 and is predicted to reach USD 95.3 Billion by the year 2034 at a 23.2% CAGR during the forecast period for 2025-2034. Immuno-oncology cell therapies are a remarkably promising treatment for a different types of cancer patients. The approval of CAR-T cell therapy products represents one of the most significant breakthroughs in cancer since the introduction of ...

Report ID: 1083  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Multi Cancer Early Detection Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Gene Panel, LDT and Others), By End-Use (Hospitals, Diagnostic Laboratories, Others), By Region, By Technology, By Sample Type And By Segment Forecasts, 2025-2034

The Multi Cancer Early Detection Market Size is valued at 1.20 Billion in 2024 and is predicted to reach 5.60 Billion by the year 2034 at a 16.8% CAGR during the forecast period for 2025-2034.  Key Industry Insights & Findings from the Report: The increasing cases of various types of cancer globally is driving the demand for early detection methods. Government initiatives and funding to support cancer r...

Report ID: 1408  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 185

Therapeutic Device Contract Manufacturing Market Size, Share & Trends Analysis Distribution by Product (Class I, Class II, and Class III), By Services (Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing, Device Manufacturing, Packaging and Labeling, and Others), By Therapeutic Area (Cardiovascular Devices, Orthopedic Devices, Ophthalmic Devices, Respiratory Devices, Surgical Instruments, Dental, and Others), By End Use (Original Equipment Manufacturers (OEMs), Pharmaceutical & Biopharmaceutical Companies, and Others), and Segment Forecasts, 2025-2034

Therapeutic Device Contract Manufacturing Market Size is valued at US$ 55.2 Bn in 2024 and is predicted to reach US$ 175.7 Bn by the year 2034 at an 12.6% CAGR during the forecast period for 2025-2034. Therapeutic device contract manufacturing provides medical device companies with a strategic and capital-efficient production model, eliminating the need for heavy investment in internal manufacturing facilities. This approach is particularly cr...

Report ID: 3249  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

GLP-1 Agonists Market Size, Share & Trends Analysis Report By Product (Branded GLP-1 Agonists, Dual / Triple, Biosimilars & Generic GLP-1 Agonists Agonists), By Indication (Type 2 Diabetes Mellitus, Obesity / Overweight Management, Cardiovascular & Metabolic Related Indications, Other Emerging Indications (e.g., NASH, Alzheimer’s-related)), By Route of Administration, By Distribution Channel, By Region and By Segments Forecasts, 2025-2034

GLP-1 Agonists Market Size is valued at USD  43.1 Bn in 2024 and is predicted to reach USD  260.1 Bn by the year 2034 at an 19.9% CAGR during the forecast period for 2025-2034. GLP-1 agonists, known to be beneficial in treating type 2 diabetes, are glucagon-like peptide-1 receptor agonists. The action of GLP-1 RAs is to enhance insulin synthesis and inhibit glucagon secretion by activating GLP-1 receptors. While all GLP-1 RAs have the ...

Report ID: 2289  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Regenerative Aesthetics Exosome Products Market Size, Share & Trends Analysis Distribution by Application (Skin Rejuvenation, Hair Restoration, Scar Reduction and Wound Healing, Anti-Inflammatory Treatments, Others), By Biological Source, By Product Format, End User (Aesthetic Clinics, Home Use, Dermatology Clinics), and Segment Forecasts, 2025-2034

Global Regenerative Aesthetics Exosome Products Market Size is valued at USD 81.1 Million in 2024 and is predicted to reach USD 1689.7 Million by the year 2034 at a 35.9% CAGR during the forecast period for 2025-2034. Regenerative aesthetics exosome products represent a cutting-edge advancement in skin rejuvenation and hair restoration, offering a minimally invasive approach. These nano-sized extracellular vesicles derived from stem cells cont...

Report ID: 2555  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 177

Categories